A Study of Nivolumab Intravenous (IV) to Subcutaneous (SC) Switch in Adjuvant Melanoma and Bladder Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
Clinical Trials Related to Bristol-Myers Squibb
Related studies linked through entity extraction aliases.
Nivolumab-ipilimumab and Chemoradiation for Cervical Cancer
- Status
- RECRUITING
- Phase
- PHASE2
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
- Status
- RECRUITING
- Phase
- N/A
Efficacy and Safety of Deucravacitinib Versus Placebo in Participants With Moderate-to-severe Scalp Psoriasis
- Status
- COMPLETED
- Phase
- PHASE4
Neoadjuvant KRAS G12C Directed Therapy With Adagrasib (MRTX849) With or Without Nivolumab
- Status
- WITHDRAWN
- Phase
- PHASE2
Oral AHR Antagonist in Combination With Nivolumab in Patients With PD-1 Resistant Metastatic or Recurrent Head and Neck Cancer
- Status
- WITHDRAWN
- Phase
- PHASE1
A Study to Evaluate the Efficacy, Safety, and Drug Levels of Oral Ozanimod in Pediatric Participants With Moderately to Severely Active Crohn's Disease With an Inadequate Response to Conventional Therapy
- Status
- TERMINATED
- Phase
- PHASE2/PHASE3
A Study to Compare the Efficacy and Safety of Oral Azacitidine Plus Best Supportive Care (BSC) Versus Placebo Plus BSC in Participants With International Prognostic Scoring System Revised (IPSS-R) Low- or Intermediate-risk Myelodysplastic Syndrome (MDS)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2/PHASE3
A Study to Assess the Effects of BMS-986371 on the Drug Levels of Methotrexate in the Presence and Absence of Sulfasalazine
- Status
- COMPLETED
- Phase
- PHASE1
A Study of VAC85135, a Neoantigen Vaccine Regimen, Concurrently Administered With Ipilimumab for the Treatment of Myeloproliferative Neoplasms
- Status
- COMPLETED
- Phase
- PHASE1
COMbination Regimens in MM Post AHCT to elimiNate MRD Utilizing IbERdomide
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
A Study of Treatment Patterns and Outcomes in Participants With Stage IIIA Melanoma Receiving Adjuvant Systemic Therapy
- Status
- COMPLETED
- Phase
- N/A
Treatment Patterns and Outcomes in Participants With Advanced Melanoma in Germany Using a German Database
- Status
- COMPLETED
- Phase
- N/A
A Post-marketing Study on the Safety of Abatacept Treatment in Denmark Using the Danish Database
- Status
- COMPLETED
- Phase
- N/A
A Study to Assess 7/8 HLA-matched Hematopoietic Stem Cell Transplantation Participants Treated With or Without Abatacept in Combination With a Calcineurin Inhibitor and Methotrexate
- Status
- COMPLETED
- Phase
- N/A
A Study of Overall Survival in Participants With Metastatic Colorectal Cancer (mCRC)
- Status
- COMPLETED
- Phase
- N/A
A Phase 2 Clinical Trial of Neoadjuvant Relatlimab and Nivolumab in High Risk, Clinical Stage II Cutaneous Melanoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study of Mavacamten in Obstructive Hypertrophic Cardiomyopathy
- Status
- COMPLETED
- Phase
- PHASE3
A Post-marketing Study to Assess the Safety of Abatacept in Sweden Using the Swedish Rheumatology Quality Register (SRQ) Register
- Status
- COMPLETED
- Phase
- N/A
An Efficacy and Safety Study of Oral Azacitidine (CC-486) as Maintenance Therapy in Chinese Participants With Acute Myeloid Leukemia in Complete Remission
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2